Comparing Long‐Term Infliximab Persistence Following a Switch to a Biosimilar in Patients With Inflammatory Bowel Disease: No Cause for Concern
Paulina Suo(UNSW Sydney), Craig Haifer(University of Sydney), Daniel R. van Langenberg(Eastern Health), Simon Ghaly(UNSW Sydney), Lena Thin(The University of Western Australia), Shankar Menon(Royal Perth Hospital), James Winston(Eastern Health), Angus W. Jeffrey(The University of Western Australia), Yoon‐Kyo An(Mater Hospital), Richard Fernandes(The University of Queensland), Thomas Skinner(UNSW Sydney), Nicholas Olsen(UNSW Sydney), Ashish Srinivasan(Eastern Health)
Cited by 0
Related Papers
Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis
|Inflammatory Bowel Diseases|2019|94
Adhesion formation after previous caesarean section-a meta-analysis and systematic review
|BJOG An International Journal of Obstetrics & Gynaecology|2010|73
Objectively measured muscle fatigue in Crohn's disease: Correlation with self-reported fatigue and associated factors for clinical application
|Journal of Crohn s and Colitis|2013|66
Gastrointestinal ultrasound in inflammatory bowel disease care: Patient perceptions and impact on disease‐related knowledge
|JGH Open|2019|62
Monitoring Inflammatory Bowel Disease in Pregnancy Using Gastrointestinal Ultrasonography
|Journal of Crohn s and Colitis|2020|62